Susan Hasty, Publisher
Table of Contents . . . June 3rd, 2002
Non-Subscriber - Summaries OnlyRelated Areas: Other Issues in Hepatitis Weekly | Other Publications
Antiviral Therapy - Lamivudine beneficial to only a few on waiting lists for liver transplants
Liver Fibrosis - Pegylated interferon - ribavirin combination limits HCV-related fibrosis
Liver Cancer - Embolization procedure extends survival in hepatocellular carcinoma
Pediatric Disease - Use of high dose hepatitis A, hepatitis B vaccine in India needs evaluation
Thalassemia - Iron depletion can reverse cirrhosis in some patients given marrow transplants
Appointments - Medizone names Steve Hanni chief financial officer
Drug Development - Company provides update of progress
Finance - Company reports 1Q record revenues
Finance - Maxygen reports first quarter 2002 results
Genetic Variants - AcroMetrix introduces hepatitis C genotyping panel
Health Education - Foundation presses Capitol Hill on health education in elementary school
Hepatitis A - Florida outbreak linked to drug use
Hepatitis B - Foundation presents award to Bill & Melinda Gates Foundation, Children's Vaccine Program
Hepatitis C - Studies: CellCept benefits patients reinfected with after liver transplant
Hepatitis G - Genelabs Technologies, University of Iowa Research Foundation collaborate on HGV, HIV research
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.